BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31379227)

  • 1. miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1).
    Chen T; Xiao Q; Wang X; Wang Z; Hu J; Zhang Z; Gong Z; Chen S
    J Int Med Res; 2019 Oct; 47(10):5194-5204. PubMed ID: 31379227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Huang Y; Zou Y; Lin L; Ma X; Zheng R
    Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
    Wang DW; Wang YQ; Shu HS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway.
    He Q; Zhou X; Li S; Jin Y; Chen Z; Chen D; Cai Y; Liu Z; Zhao T; Wang A
    Biochim Biophys Acta; 2013 Nov; 1830(11):5258-66. PubMed ID: 23911747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway.
    Lu S; Xu Q
    IUBMB Life; 2019 May; 71(5):587-600. PubMed ID: 30589231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.
    Chen LZ; Ding Z; Zhang Y; He ST; Wang XH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
    J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
    Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
    BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
    Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
    Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells.
    Xiao Y; Li X; Wang H; Wen R; He J; Tang J
    J Cell Mol Med; 2015 Sep; 19(9):2172-80. PubMed ID: 26081366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
    Liu X; Ma J; Xu F; Li L
    Biomed Pharmacother; 2018 Mar; 99():9-17. PubMed ID: 29324317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
    Cui R; Meng W; Sun HL; Kim T; Ye Z; Fassan M; Jeon YJ; Li B; Vicentini C; Peng Y; Lee TJ; Luo Z; Liu L; Xu D; Tili E; Jin V; Middleton J; Chakravarti A; Lautenschlaeger T; Croce CM
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4288-97. PubMed ID: 26187928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.
    Liu J; Liu S; Deng X; Rao J; Huang K; Xu G; Wang X
    PLoS One; 2019; 14(6):e0217652. PubMed ID: 31170211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
    Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
    Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.